Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
← catalyst calendarNCT07038473 · readout in 127 d
Sponsored by Sanofi (industry) · SNY — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Diagnostic
Enrollment
3,500estimated
Sites
7
Countries
Kuwait, Saudi Arabia, United Arab Emirates
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-12-17 | actual | When the study began enrolling |
| Primary completion | 2026-12-25 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-12-25 | estimated | The whole study's end, after follow-up |
| First posted | 2025-06-26 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Type 1 Diabetes
Intervention
- Procedure: Investigational Procedure
Primary outcome
what the primary-completion date above is the date OFProportion of at-risk (first-degree) relatives of T1D probands who meet the diagnostic criteria for Stage 1 or Stage 2 T1D
measured At Baseline (screening visit) and in 3 months, at Visit 2 (confirmatory visit)
Permalink · SNY's whole pipeline · Catalyst calendar · Every registered study · What changed